FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912162368> ?p ?o ?g. }

• W2912162368 endingPage "1306" @default.
• W2912162368 startingPage "1299" @default.
• W2912162368 abstract "Commercial and regulatory limitations associated with native porcine zona pellucida (pZP) vaccines formulated with Freund’s adjuvants may be overcome by developing effective recombinant ZP vaccines (reZP) and identifying alternative adjuvant formulations. A two-part preparatory study used 15 geldings and identified potentially effective alternative adjuvant formulations based on anti-pZP antibody response following treatment with pZP formulated with Addavax (AddaVax ™, Invivogen), Quil A (Quil-A® Adjuvant, Invivogen), Quil A and Poly (I:C) (HMW VacciGrade™, Invivogen), Pet Gel A (Montanide™ Pet Gel A, Seppic) and Pet Gel A and Poly (I:C). Injection site reactions, rectal temperature and respiratory and heart rates were also monitored for three days post-treatment. Suitable anti-pZP antibody titres were seen in response to Pet Gel A and Pet Gel A and Poly (I:C). Subsequently in 31 mares, following administration of pZP, reZP and a combination of pZP and reZP proteins prepared in Pet Gel A and Poly (I:C), both serum anti-pZP and -reZP antibody responses were monitored. In addition, safety was assessed for up to seven days post-treatment by inspection and palpation of gluteal intramuscular injection sites and measurement of rectal temperature. The measured antibody titres in all treatment groups differed significantly to an adjuvant control group (P < 0.001). Temporal changes in both anti-pZP and -reZP antibody titres in all ZP treatment groups were similar to patterns reported previously in various species vaccinated with pZP formulated with Freund’s adjuvants. There were no differences in anti-pZP antibody titres between the pZP and reZP treated groups (P > 0.05). Side effects were mild and transient in nature. This represents the first application of a reZP vaccine formulated with non-Freund’s adjuvants evoking a similar antibody titre response to native pZP vaccination in mares." @default.
• W2912162368 created "2019-02-21" @default.
• W2912162368 creator A5019797422 @default.
• W2912162368 creator A5026316484 @default.
• W2912162368 creator A5064735572 @default.
• W2912162368 creator A5067326294 @default.
• W2912162368 creator A5069988638 @default.
• W2912162368 creator A5071844168 @default.
• W2912162368 creator A5076779706 @default.
• W2912162368 date "2019-02-01" @default.
• W2912162368 modified "2023-09-25" @default.
• W2912162368 title "Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund’s adjuvant in horses" @default.
• W2912162368 cites W1481166519 @default.
• W2912162368 cites W1507514895 @default.
• W2912162368 cites W1623183308 @default.
• W2912162368 cites W1908016483 @default.
• W2912162368 cites W1963590985 @default.
• W2912162368 cites W1969002048 @default.
• W2912162368 cites W1970283537 @default.
• W2912162368 cites W1974546926 @default.
• W2912162368 cites W1974848121 @default.
• W2912162368 cites W1988070981 @default.
• W2912162368 cites W1995400848 @default.
• W2912162368 cites W2003055084 @default.
• W2912162368 cites W2009746224 @default.
• W2912162368 cites W2009768595 @default.
• W2912162368 cites W2017866378 @default.
• W2912162368 cites W2018544077 @default.
• W2912162368 cites W2020617923 @default.
• W2912162368 cites W2037177370 @default.
• W2912162368 cites W2068295275 @default.
• W2912162368 cites W2076536630 @default.
• W2912162368 cites W2077542228 @default.
• W2912162368 cites W2087952403 @default.
• W2912162368 cites W2089826191 @default.
• W2912162368 cites W2106781193 @default.
• W2912162368 cites W2107999555 @default.
• W2912162368 cites W2124259081 @default.
• W2912162368 cites W2140116392 @default.
• W2912162368 cites W2140131324 @default.
• W2912162368 cites W2167708878 @default.
• W2912162368 cites W2168100494 @default.
• W2912162368 cites W2169394902 @default.
• W2912162368 cites W2205938161 @default.
• W2912162368 cites W2312778396 @default.
• W2912162368 cites W2345713210 @default.
• W2912162368 cites W2394507166 @default.
• W2912162368 cites W2519482585 @default.
• W2912162368 cites W2557909303 @default.
• W2912162368 cites W2885728572 @default.
• W2912162368 cites W2886829817 @default.
• W2912162368 cites W2903182601 @default.
• W2912162368 cites W2064368272 @default.
• W2912162368 doi "https://doi.org/10.1016/j.vaccine.2019.01.053" @default.
• W2912162368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30733089" @default.
• W2912162368 hasPublicationYear "2019" @default.
• W2912162368 type Work @default.
• W2912162368 sameAs 2912162368 @default.
• W2912162368 citedByCount "11" @default.
• W2912162368 countsByYear W29121623682019 @default.
• W2912162368 countsByYear W29121623682020 @default.
• W2912162368 countsByYear W29121623682021 @default.
• W2912162368 countsByYear W29121623682022 @default.
• W2912162368 countsByYear W29121623682023 @default.
• W2912162368 crossrefType "journal-article" @default.
• W2912162368 hasAuthorship W2912162368A5019797422 @default.
• W2912162368 hasAuthorship W2912162368A5026316484 @default.
• W2912162368 hasAuthorship W2912162368A5064735572 @default.
• W2912162368 hasAuthorship W2912162368A5067326294 @default.
• W2912162368 hasAuthorship W2912162368A5069988638 @default.
• W2912162368 hasAuthorship W2912162368A5071844168 @default.
• W2912162368 hasAuthorship W2912162368A5076779706 @default.
• W2912162368 hasConcept C104317684 @default.
• W2912162368 hasConcept C126322002 @default.
• W2912162368 hasConcept C159654299 @default.
• W2912162368 hasConcept C16685009 @default.
• W2912162368 hasConcept C185592680 @default.
• W2912162368 hasConcept C196843134 @default.
• W2912162368 hasConcept C203014093 @default.
• W2912162368 hasConcept C2776010925 @default.
• W2912162368 hasConcept C2776291583 @default.
• W2912162368 hasConcept C2776690073 @default.
• W2912162368 hasConcept C2777863537 @default.
• W2912162368 hasConcept C40767141 @default.
• W2912162368 hasConcept C55493867 @default.
• W2912162368 hasConcept C71924100 @default.
• W2912162368 hasConcept C86803240 @default.
• W2912162368 hasConcept C95444343 @default.
• W2912162368 hasConceptScore W2912162368C104317684 @default.
• W2912162368 hasConceptScore W2912162368C126322002 @default.
• W2912162368 hasConceptScore W2912162368C159654299 @default.
• W2912162368 hasConceptScore W2912162368C16685009 @default.
• W2912162368 hasConceptScore W2912162368C185592680 @default.
• W2912162368 hasConceptScore W2912162368C196843134 @default.
• W2912162368 hasConceptScore W2912162368C203014093 @default.
• W2912162368 hasConceptScore W2912162368C2776010925 @default.
• W2912162368 hasConceptScore W2912162368C2776291583 @default.
• W2912162368 hasConceptScore W2912162368C2776690073 @default.

• next